Shanghai, Sinopharm in jealous snit over investors

A spat between two Chinese drug companies--Sinopharm and Shanghai Pharmaceuticals--highlights how that country's state-run companies are increasingly competing as vigorously with one another as they do with foreign rivals. Report

Suggested Articles

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.

ICER said that Vertex's triplet CF therapy Trikafta would only be cost effective if the price were dropped from $311,000 to no more than $85,500.